BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 21924942)

  • 1. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
    Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
    Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson's disease.
    Lin CH; Wu RM; Tai CH; Chen ML; Hu FC
    Parkinsonism Relat Disord; 2011 Feb; 17(2):84-8. PubMed ID: 21167764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
    Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
    Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
    Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
    Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies.
    Xie CL; Pan JL; Wang WW; Zhang Y; Zhang SF; Gan J; Liu ZG
    Neurol Sci; 2014 Oct; 35(10):1495-504. PubMed ID: 25027012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals.
    Dan X; Wang C; Ma J; Feng X; Wang T; Zheng Z; Chan P
    Neurobiol Aging; 2014 Jul; 35(7):1780.e7-1780.e10. PubMed ID: 24559644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
    Yu L; Hu F; Zou X; Jiang Y; Liu Y; He X; Xi J; Liu L; Liu Z; He L; Xu Y
    Brain Res; 2009 Nov; 1296():113-6. PubMed ID: 19699188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease.
    Bardien S; Lesage S; Brice A; Carr J
    Parkinsonism Relat Disord; 2011 Aug; 17(7):501-8. PubMed ID: 21641266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
    Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
    J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lrrk2 R1628P variant is a risk factor for essential tremor.
    Chao YX; Ng EY; Tan L; Prakash KM; Au WL; Zhao Y; Tan EK
    Sci Rep; 2015 Mar; 5():9029. PubMed ID: 25761573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical molecular genetics for PARK8 (LRRK2)].
    Tomiyama H; Hatano T; Hattori N
    Brain Nerve; 2007 Aug; 59(8):839-50. PubMed ID: 17713120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: a case-control study in Japan.
    Miyake Y; Tsuboi Y; Koyanagi M; Fujimoto T; Shirasawa S; Kiyohara C; Tanaka K; Fukushima W; Sasaki S; Yamada T; Oeda T; Miki T; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
    J Neurol Sci; 2010 Oct; 297(1-2):15-8. PubMed ID: 20673920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson's disease: a meta-analysis.
    Wu X; Tang KF; Li Y; Xiong YY; Shen L; Wei ZY; Zhou KJ; Niu JM; Han X; Yang L; Feng GY; He L; Qin SY
    Parkinsonism Relat Disord; 2012 Jul; 18(6):722-30. PubMed ID: 22575234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
    Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
    Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of LRRK2 A419V variant in ethnic Chinese.
    Li NN; Tan EK; Chang XL; Mao XY; Zhang JH; Zhao DM; Liao Q; Peng R
    Neurobiol Aging; 2012 Aug; 33(8):1849.e1-3. PubMed ID: 22418733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.
    Cao M; Gu ZQ; Li Y; Zhang H; Dan XJ; Cen SS; Li DW; Chan P
    Neurosci Bull; 2016 Dec; 32(6):572-576. PubMed ID: 27699718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants ofLRRK2 in Taiwanese Parkinson's disease.
    Wu YR; Chang KH; Chang WT; Hsiao YC; Hsu HC; Jiang PR; Chen YC; Chao CY; Chang YC; Lee BH; Hu FJ; Chen WL; Lee-Chen GJ; Chen CM
    PLoS One; 2013; 8(12):e82001. PubMed ID: 24339985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease.
    Hong JH; Kim YK; Park JS; Lee JE; Oh MS; Chung EJ; Kim JY; Sung YH; Lyoo CH; Lee JH; Kwon DY; Kim HS; Shin HW; Park SA; Park IS; Kim JS; Lee PH; Koh SB; Baik JS; Kim SJ; Ma HI; Kim JW; Kim YJ
    J Clin Neurosci; 2017 Feb; 36():108-113. PubMed ID: 27839916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between the LRRK2 A419V variant and Asian Parkinson's disease.
    Gopalai AA; Lim SY; Aziz ZA; Lim SK; Tan LP; Chong YB; Tan CT; Puvanarajah S; Viswanathan S; Kuppusamy R; Tan AH; Lim TT; Eow GB; Norlinah MI; Li HH; Zhao Y; Ahmad-Annuar A
    Ann Acad Med Singap; 2013 May; 42(5):237-40. PubMed ID: 23771111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.